A Lack of Premature Termination Codon Read-Through Efficacy of PTC124 (Ataluren) in a Diverse Array of Reporter Assays
出版年份 2013 全文链接
标题
A Lack of Premature Termination Codon Read-Through Efficacy of PTC124 (Ataluren) in a Diverse Array of Reporter Assays
作者
关键词
Nonsense mutation, Collagens, Transient transfection assay, Insertion mutation, Luciferase, Drug discovery, Site-directed mutagenesis, Transfection
出版物
PLOS BIOLOGY
Volume 11, Issue 6, Pages e1001593
出版商
Public Library of Science (PLoS)
发表日期
2013-06-26
DOI
10.1371/journal.pbio.1001593
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Readthrough of long-QT syndrome type 1 nonsense mutations rescues function but alters the biophysical properties of the channel
- (2012) Stephen C. Harmer et al. BIOCHEMICAL JOURNAL
- The Chemical Compound PTC124 Does Not Affect Cellular Electrophysiology of Cardiac Ventricular Myocytes
- (2011) Tamara T. Koopmann et al. CARDIOVASCULAR DRUGS AND THERAPY
- Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
- (2011) M. Wilschanski et al. EUROPEAN RESPIRATORY JOURNAL
- PTC124-Mediated Translational Readthrough of a Nonsense Mutation Causing Usher Syndrome Type 1C
- (2011) T. Goldmann et al. HUMAN GENE THERAPY
- The international dystrophic epidermolysis bullosa patient registry: An online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations
- (2011) Peter C. van den Akker et al. HUMAN MUTATION
- PTC124 improves readthrough and increases enzymatic activity of the CPT1A R160X nonsense mutation
- (2011) Lu Tan et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Stop codon read-through with PTC124 induces palmitoyl-protein thioesterase-1 activity, reduces thioester load and suppresses apoptosis in cultured cells from INCL patients
- (2011) Chinmoy Sarkar et al. MOLECULAR GENETICS AND METABOLISM
- Rescue of Melanocortin 4 Receptor (MC4R) Nonsense Mutations by Aminoglycoside-Mediated Read-Through
- (2011) Harald Brumm et al. Obesity
- Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis
- (2010) Isabelle Sermet-Gaudelus et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Cutting the nonsense: the degradation of PTC-containing mRNAs
- (2010) Pamela Nicholson et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Illuminating Insights into Firefly Luciferase and Other Bioluminescent Reporters Used in Chemical Biology
- (2010) Natasha Thorne et al. CHEMISTRY & BIOLOGY
- Membrane blebbing as an assessment of functional rescue of dysferlin-deficient human myotubes via nonsense suppression
- (2010) Bingjing Wang et al. JOURNAL OF APPLIED PHYSIOLOGY
- Nonsense suppressor therapies rescue peroxisome lipid metabolism and assembly in cells from patients with specific PEX gene mutations
- (2010) Patricia K. Dranchak et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124
- (2010) D. S. Auld et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nonsense suppression activity of PTC124 (ataluren)
- (2009) S. W. Peltz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression
- (2009) D. S. Auld et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial
- (2008) Eitan Kerem et al. LANCET
- PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model
- (2008) M. Du et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started